Literature DB >> 9890255

Involvement of stress in the sleep rebound mechanism induced by sleep deprivation in the rat: use of alpha-helical CRH (9-41).

M M González1, J L Valatx.   

Abstract

A previous study demonstrated the efficacy of the corticotropin-releasing hormone (CRH) receptor antagonist, alpha-helical CRH (9-41), in blocking the paradoxical sleep increase induced by stress. In the present study, this peptide was used to evaluate the involvement of the stress component of the sleep deprivation, in the paradoxical sleep rebound. Rats were subjected for 10 h to the classical water-tank sleep-deprivation technique and were given, every 2 h throughout the sleep deprivation period, intracerebroventricular injections of either 100 microg/5 microl of alpha-helical CRH (9-41) or vehicle alone. Continuous recordings showed that antagonist treatment decreased the PS rebound, but not the SWS rebound, following sleep deprivation. These findings suggest that, in the water-tank sleep deprivation method, stress, acting via CRH activation, is the main factor inducing the paradoxical sleep rebound.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9890255     DOI: 10.1097/00008877-199812000-00001

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  10 in total

1.  Effects of corticotropin releasing factor (CRF) on sleep and body temperature following controllable footshock stress in mice.

Authors:  L Yang; L L Wellman; X Tang; L D Sanford
Journal:  Physiol Behav       Date:  2011-05-30

2.  Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice.

Authors:  Benjamin Boutrel; Christelle Monaca; Rene Hen; Michel Hamon; Joelle Adrien
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

3.  Corticotropin releasing factor (CRF) modulates fear-induced alterations in sleep in mice.

Authors:  Linghui Yang; Xiangdong Tang; Laurie L Wellman; Xianling Liu; Larry D Sanford
Journal:  Brain Res       Date:  2009-04-17       Impact factor: 3.252

4.  Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of corticotropin-releasing factor.

Authors:  Laurie L Wellman; Linghui Yang; Marta A Ambrozewicz; Mayumi Machida; Larry D Sanford
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

5.  Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness.

Authors:  L D Sanford; L Yang; L L Wellman; E Dong; X Tang
Journal:  Brain Res       Date:  2007-11-12       Impact factor: 3.252

6.  Modulation of Sleep Homeostasis by Corticotropin Releasing Hormone in REM Sleep-Deprived Rats.

Authors:  Ricardo Borges Machado; Sergio Tufik; Deborah Suchecki
Journal:  Int J Endocrinol       Date:  2010-06-13       Impact factor: 3.257

7.  Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression.

Authors:  Thomas Fenzl; Chadi Touma; Christoph Pn Romanowski; Jörg Ruschel; Florian Holsboer; Rainer Landgraf; Mayumi Kimura; Alexander Yassouridis
Journal:  BMC Neurosci       Date:  2011-03-24       Impact factor: 3.288

8.  Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep.

Authors:  M Kimura; P Müller-Preuss; A Lu; E Wiesner; C Flachskamm; W Wurst; F Holsboer; J M Deussing
Journal:  Mol Psychiatry       Date:  2009-05-19       Impact factor: 15.992

9.  Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression.

Authors:  Chadi Touma; Thomas Fenzl; Jörg Ruschel; Rupert Palme; Florian Holsboer; Mayumi Kimura; Rainer Landgraf
Journal:  PLoS One       Date:  2009-01-29       Impact factor: 3.240

10.  Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice.

Authors:  Laurie L Wellman; Linghui Yang; Larry D Sanford
Journal:  Front Neurosci       Date:  2015-07-30       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.